国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Elephantid herpesvirus 1 Tripartite terminase subunit UL15 homolog, partial CSB-YP621167EAAN
CSB-EP621167EAAN
CSB-BP621167EAAN
CSB-MP621167EAAN
CSB-EP621167EAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elephantid herpesvirus 1 Triplex capsid protein U56 CSB-YP621168EAAN
CSB-EP621168EAAN
CSB-BP621168EAAN
CSB-MP621168EAAN
CSB-EP621168EAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elephantid herpesvirus 1 Protein ORF D CSB-YP621169EAAN
CSB-EP621169EAAN
CSB-BP621169EAAN
CSB-MP621169EAAN
CSB-EP621169EAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elephantid herpesvirus 1 Protein ORF B, partial CSB-YP621170EAAN
CSB-EP621170EAAN
CSB-BP621170EAAN
CSB-MP621170EAAN
CSB-EP621170EAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Suncus murinus Mitochondrial brown fat uncoupling protein 1 (UCP1), partial CSB-YP621171FPS1
CSB-EP621171FPS1
CSB-BP621171FPS1
CSB-MP621171FPS1
CSB-EP621171FPS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Takifugu rubripes Ammonium transporter Rh type B (rhbg), partial CSB-YP621172TKY
CSB-EP621172TKY
CSB-BP621172TKY
CSB-MP621172TKY
CSB-EP621172TKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class delta-59 (srd-59), partial CSB-YP621173CXY
CSB-EP621173CXY
CSB-BP621173CXY
CSB-MP621173CXY
CSB-EP621173CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant LIM domain-containing protein pin-2 (pin-2) CSB-YP621174CXY
CSB-EP621174CXY
CSB-BP621174CXY
CSB-MP621174CXY
CSB-EP621174CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class gamma-69 (srg-69), partial CSB-YP621175CXY1
CSB-EP621175CXY1
CSB-BP621175CXY1
CSB-MP621175CXY1
CSB-EP621175CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative neurobeachin homolog (sel-2), partial CSB-YP621176CXY
CSB-EP621176CXY
CSB-BP621176CXY
CSB-MP621176CXY
CSB-EP621176CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative pyridoxal-phosphate dependent protein F13B12.4 (F13B12.4) CSB-YP621177CXY
CSB-EP621177CXY
CSB-BP621177CXY
CSB-MP621177CXY
CSB-EP621177CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Inositol monophosphatase ttx-7 (ttx-7) CSB-YP621178CXY
CSB-EP621178CXY
CSB-BP621178CXY
CSB-MP621178CXY
CSB-EP621178CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant D-aspartate oxidase 1 (F18E3.7) CSB-YP621179CXY
CSB-EP621179CXY
CSB-BP621179CXY
CSB-MP621179CXY
CSB-EP621179CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 125R (IIV3-125R) CSB-YP621180IAAL
CSB-EP621180IAAL
CSB-BP621180IAAL
CSB-MP621180IAAL
CSB-EP621180IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 115R (IIV3-115R) CSB-YP621181IAAL
CSB-EP621181IAAL
CSB-BP621181IAAL
CSB-MP621181IAAL
CSB-EP621181IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Putative hydrolase 111R (IIV3-111R) CSB-YP621182IAAL
CSB-EP621182IAAL
CSB-BP621182IAAL
CSB-MP621182IAAL
CSB-EP621182IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 106R (IIV3-106R) CSB-YP621183IAAL
CSB-EP621183IAAL
CSB-BP621183IAAL
CSB-MP621183IAAL
CSB-EP621183IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Putative ribonuclease 3 (IIV3-101R) CSB-YP621184IAAL
CSB-EP621184IAAL
CSB-BP621184IAAL
CSB-MP621184IAAL
CSB-EP621184IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Putative MSV199 domain-containing protein 093L (IIV3-093L) CSB-YP621185IAAL
CSB-EP621185IAAL
CSB-BP621185IAAL
CSB-MP621185IAAL
CSB-EP621185IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Probable DNA-directed RNA polymerase II subunit RPB1 homolog (IIV3-090L), partial CSB-YP621186IAAL
CSB-EP621186IAAL
CSB-BP621186IAAL
CSB-MP621186IAAL
CSB-EP621186IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>